RecruitingNot ApplicableNCT03094026

Cognitive Training Intervention and Attitudes Towards Genetics

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation

Sponsor

University of Alabama at Birmingham

Enrollment

60 participants

Start Date

Aug 21, 2017

Study Type

INTERVENTIONAL

Conditions

Cognitive Impairment Hematologic Neoplasms Hematopoietic Cell Transplant

Summary

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Lumosity and a behavioral approach called Lumosity (waitlist control) for people with cognitive impairment, hematologic neoplasms, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALLumosity

Computer-based online cognitive training program using the Lumosity cognitive training program.

BEHAVIORALLumosity (waitlist control)

Computer-based online cognitive training program using the Lumosity cognitive training program. The control group will receive the intervention after a waiting period of 12 weeks.